Skip to NavigationSkip to content

News

0
Pfizer first company to sign up to scheme to accelerate treatments, with the goal to stop breast cancer deaths by 2050
0
Briefing document from the Arthritis Advisory Committee suggests Celltrion’s CT-P13 “highly similar” to Janssen’s reference drug
0
Regulator backs Repatha, having rejected the drug in draft guidance last year
0
Minister for Health says patients often only report to healthcare facilities when the cancer is at an advanced and untreatable stage

Features

Dr Edward Wright, virologist and senior lecturer in medical microbiology, University of Westminster, on the extent of the Zika crisis and the race...